Homœopathic Links 2020; 33(03): 145-146
DOI: 10.1055/s-0040-1715603

COVID-19: Adversities and Opportunities

Isaac Golden
1  Human Ethics Committee, National Institute of Integrative Medicine, Gisborne, Australia
› Author Affiliations

The 2020 global pandemic of coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (CV19) has changed the world.

The fact that we still do not know with certainty many things about CV19 has led to a myriad of conspiracy theories about where it started, how it started, why it started, did it naturally start or was it created, was its spread an accident or was it deliberate? And then the Internet and the news media are flooded with stories of forthcoming vaccine developments and pharmaceutical treatment options.

The international pharmaceutical drug cartels are salivating at the prospects that await them, and already they have been gifted billions of dollars from governments to ‘make us safe’. Old toxic drug therapies have been resurrected and we are promised that vaccine developments will be fast tracked, thus avoiding normal safety studies, as if that is a good thing.

There is understandable confusion over many aspects of the pandemic, including even a simple matter of whether it is better to wear a mask or not wear one, with learned scientists voicing opposite opinions and citing research to support their differing views.

And then we have homeopathy, with the capacity to offer safe and inexpensive treatment and prevention options, some of which have been tested in epidemics over hundreds of years. But very few governments are listening because the drug cartels have their attention and the politicians, like their citizens, are mesmerised by fear.

This edition of Homeopathic Links offers some valuable insights into the CV19 situation.

Professor A.M. Macias examines the importance of NOS2 and AOC1 genes in the development, how the symptoms, their inhibition of CV19, and suggests that by understanding how the symptoms their inhibition or underexpression can generate leads us to consider Arsenicum album and Silicea terra as therapeutic possibilities.

Dr Gurudev Choubey argues that the usefulness of therapeutic agent as prophylaxis is recognised only after obtaining significant result in prophylactic clinical trial. He then suggests a range of methods to employ to conduct a trial to confirm prophylactic effectiveness.

Dr Hima Bindu Ponnam observes that fear of infection is a significant issue arising from CV19, and may create more genuine health issues than the virus itself. Two cases are presented to illustrate the argument, and once again Arsenicum album is seen as being a strongly indicated remedy.

Dr P. Rath and Dr S.N. Jana point out that despite the long and positive history homeopathy has in dealing well with epidemics, it has been largely ignored as an option. They reviewed several articles presenting cases in epidemic situations, including CV19, and made suggestions for treatment. They also tabulated clinical syndromes associated with CV19 and suggested medicines. They argued that homeopathy be allowed to take its place alongside other therapies for treatment and prevention.

Dr J. Gupta and Dr S. Gupta discuss the relevance of the classical homeopathic approach to the current CV19 situation. They began with an examination of the medical details of CV19, and then conducted a homeopathic literature search to support their thesis that immunomodulation caused by a similar homeopathic remedy is needed to prevent and treat CV19. They also support the use of tautopathy in the current situation.

Dr J.K. Dey, Dr S.K. Dey and H. Sihag examine some of what is known about CV19, including potential pharmaceutical treatments. They then consider what is known about possible homeopathic treatments, and find that the remedies Bryonia alba, Arsenicum album, Gelsemium sempervirens are working best till now. They call for urgent research to understand how these medicines are working to cure CV19 and how that could then be used to develop even more effective treatments.

Finally Dr B. Sharma and Dr P. Misra examine the psychological impact of CV19. They searched a wide range of journals and other sources and concluded that there is a real need for research among vulnerable populations to study the long-term psychological effects of CV19.

It is likely that CV19 will be the defining factor of this decade. Even if its clinical impact dwindles in the coming years, its economic and social impact will be felt for much longer. The contributions have examined a range of ideas and experiences concerning how to deal with CV19.

Many questions remain: Will a truly honest history of the epidemic ever be known and described? Will the resulting panic be used by unscrupulous people to make themselves even more wealthy, and to restrict basic human rights and freedoms? Or will a new way of thinking emerge that will progress what is good in humanity, and breakdown existing inequalities between those who have resources, and those who do not?

Will homeopathic medicine, which right now has so much to offer the entire planet both as a treatment and a prevention option, be allowed to be used internationally? Or will the pharmaceutical drug cartels maintain their stranglehold on most national health care systems and political leaders, and ensure that even though their offerings are limited, that proven natural options like homeopathy are not allowed to be used.

The CV19 pandemic may lead the planet down two very different paths—we can only hope and pray that the light of truth shines over the path we finally will take together.

Publication History

Publication Date:
16 September 2020 (online)

© 2020. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Private Ltd.